The principles of the United Kingdom national external quality assessment scheme in various pathology disciplines have been reviewed by Whitehead and Woodford' and the operation of the scheme for microbiology during 1974-80 has been described elsewhere.2 The UK scheme is voluntary but all laboratories concerned with examining specimens relevant to care of patients are encouraged to participate and the rate of compliance appears to be high. Laboratories participating in microbiology receive and report on simulated specimens in a number of categories, of which the largest is general bacteriology (bacterial isolation and identification). Participants are given a score for each of the specimens they examine, and the scores Accepted for publication 15 January 1985 are reported back to the participants in confidence. In general bacteriology, analysis of six monthly cumulative scores gives each laboratory an assessment of its overall performance and allows definition of laboratories whose performance is significantly worse than average.
In 1975 Hart3 described the distribution of simulated specimens for virus isolation or assay of antibodies against influenza and rubella to up to 60 laboratories in the UK. This nucleus of external quality assessment (EQA) in virology was developed further, and in 1980 there were five categories of virology-that is, virus isolation, general virus serology, rubella serology, hepatitis B surface antigen detection, and electron microscopy.2 Participants in virology, however, received no individual appraisal of their results, as was the case for general clinical bacteriology. Since 1980 the scheme for EQA in virology has been further extended. 534 United Kingdom scheme for external quality assessment in virology. Part I Improved procedures for preparation and predistribution assessment of specimens have been established, and methods of scoring results have been defined. Computer systems for storage and analysis of records have been developed, giving participants printed records of their scores and cumulative performance ratings. As in general bacteriology, laboratories whose cumulative scores are significantly below average have been identified.
The first intention of the scheme is to provide participating laboratories with well documented virological specimens with which to monitor their work and to evaluate the performance of each laboratory by comparison with others examining the same specimens. As in EQA for general clinical bacteriology, individual laboratories' results, scores, and cumulative performance ratings are strictly confidential: participants' reports are identified by laboratory code numbers and the addresses associated with these codes are available only to relevant members of staff. However, advice from the National Advisory Panel for Microbiology is made available to any laboratories whose performance is significantly worse than average, although the identity of such laboratories is made known to the panel only in exceptional circumstances, if poor performances persists over a prolonged period.
The virology scheme also provides participating laboratories with technical information and perhaps with a means of self education. In addition to reporting on each specimen, participants are asked to Reed, Gardner, Snell, Chai Electron microscopy serum samples may restrict the dispatch of speciAgain, simulated specimens are distributed for mens, and this applies particularly to samples negaidentification of viruses and the scores allocated tive for rubella antibody or containing rubella 1gM depend on the accuracy of identification.
antibody. Sets of specimens in most of these categories are distributed twice yearly, roughly every six to seven PARTICIPANTS IN THE SCHEME months, although only one distribution a year has so The scheme is intended mainly for participants in far been made for electron microscopy and rubella the UK, but a number of non-UK laboratories are IgM (Table 1 ). The limited availability of human also enrolled. For reasons of resources and organisa- 292, 289, 285, 281, 277, 275, 267, 263, 260, 257 Assessment of participants' cumulative performances resembles that used for EQA in general bacteriology. For virology, however, cumulative scores and performance ratings are calculated for the preceding 12 months, whereas a six month period is used in bacteriology. In virology, laboratories are given one performance rating for the preceding year's specimens within each single distribution type-for example, hepatitis B-and another for combined distributions, comprising all the virological EQA specimens examined by that laboratory in the preceding year. The calculation of the perforReed, Gardner, Snell, Chai mance rating is based on the method described by Tillett and Crone. 4 The rating is the number of standard errors by which the participant's cumulative score for the preceding 12 months differs from the mean, and the mean with which each individual laboratory's performance is compared is calculated from the results of all participants examining the same specimens as the individual concerned. The performance rating carries a + or -sign, indicating whether performance is above or below the mean. The differences from the mean are likely to be significant only if the performance rating is >+ 1.96 or <-1-96.
A laboratory's performance rating (p) is m-r standard error of r where m = the sum of that laboratory's scores for the specimens submitted and r = the mean score achieved by all laboratories examining those specimens. The mean (r) and its standard error against which the individuarls cumulative performance is judged is calculated as shown below for each individual laboratory using the specimen means (t) for all the specimens submitted to that laboratory. Inclusion of all the appropriate specimen means makes allowances for some specimens having proved more difficult than others; a laboratory that has examined mainly difficult specimens is not compared with a mean derived from easy specimens.
Where f = score of each laboratory examining a particular specimen and w = total number of laboratories scored for that specimen (including those scored zero for failing to return a report) Performance ratings for participants in the UK and British armed forces are derived from means calculated for these participants only, whereas performance ratings for overseas participants are derived from means calculated for all participants (UK, British armed forces, and overseas).
Performance ratings of less than -1-96 are considered to be significantly worse than average and to indicate poor performance in individual or combined distribution types. Performance ratings calculated for the preceding year's specimens may be derived from as few as four specimens (electron microscopy) or as many as 30 or more (combined distributions), and the numbers of participants concemed may vary from about 55 (electron micros-United Kingdom scheme for e-xternal quality assessment in virology. Part 1 copy) to about 200. Even with small numbers of specimens and participants, however, as in electron microscopy, the probability that a poor performance cumulative score would occur by chance is low (p < 0-025) and is in good agreement with the exact probability computed from all possible combinations of scores (J Lobb, personal communication) . The latter approach requires too much computation to be adopted routinely.
PERIODICAL ASSESSMENTS OF PERFORMANCE
The Figure shows the distribution of performance ratings for participants in the UK and British armed forces for each distribution type separately and five distribution types combined (combined analysis). For rubella antibody detection and HBsAg detection most participants' ratings are close to the average, but in general serology, virus identification, and electron microscopy ratings are more widely distributed. In virus identification, electron microscopy, and combined analysis the performance ratings of a number of participants lie between +0-67 and + 1-65 standard errors above the mean, and for combined analysis a few performance ratings significantly above the average-that is, >+1-96-have been recorded. The proportion of poor performers-that is, those laboratories with ratings Perforrance ratings (groups) Performance ratings ofparticipants in virology external quality assessment analysed for five separate distribution types and for all distribution types combined. The ratings have been grouped into the following categories; a <-3.3; b -3-3 to <-2-6; c -2-6 to <-1 96; d -1 .96 to <-1 65; e -1-65 to <-0-67; f-067 to <00; g 0.0 to <+067; h 0-67 to < +1-65; i +1-65 to < +1 96; j +1 .96. Ratings of <1 -96, indicating potential poor performance, are shown as dark columns <-1 96-is about 5% for rubella serology and HBsAg detection and 8 or 9% for other distribution types and for combined analysis. Poor performance in combined analysis is usually associated with poor performance in one or more of the distribution types analysed singly, but the converse is not always the case. From 1984 it is anticipated that participants with performance ratings <-1-96 will be defined by analyses carried out each January and July, each analysis being retrospective for 12 months. The attention of participants whose performance ratings are <-1-96 will, in confidence, be drawn to this fact. If poor performance in an individual laboratory should persist a procedure similar to that used in EQA of general bacteriology will be followed and the participant will be offered the advice of the National Advisory Panel for Microbiology.
ANALYSIS OF PARTICIPANTS' METHODS
A request for participants to report on their methods accompanies all EQA specimens for virology except for general virus serology (complement fixation tests). Information on the methods participants use for each specimen is analysed in the EQA laboratory and reported back to the participants in the distribution summaries. New The allocation of scores of 2, 1, 0, or -1 for each specimen has been well accepted by participants, as have the performance ratings in individual and combined distribution types. It has been evident that the receipt of their chits (Table 4) has focused the attention of participants on the extent to which their own performance is above or below average and has helped them to identify problem areas which may include clerical or administrative deficiencies. Participants are advised to treat all EQA specimens as if they were routine specimens from patients, but this advice is not always followed and it is probable that performance ratings in EQA often represent a laboratory's best rather than its average work. But the virology EQA scheme should, perhaps over a period of months or years, improve the overall standard of work. Such an improvement might be documented as a change in the distribution of performance ratings (Figure) or as an increase in the overall mean score (specimen mean) for difficult categories of specimen for which the mean scores are sometimes low (p 542). 
